Published in PLoS One on August 17, 2011
Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology (2014) 2.98
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J (2012) 2.21
MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol (2013) 2.04
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
Retracted Risk miRNA screening of ovarian cancer based on miRNA functional synergistic network. J Ovarian Res (2014) 1.40
MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One (2012) 1.11
MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med (2014) 1.08
The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech (2013) 1.01
MicroRNAs in bile vesicles: finding a trade-off for biomarker discovery. Hepatology (2015) 0.99
High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. Oncol Rep (2013) 0.99
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS One (2012) 0.98
MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J Surg Oncol (2014) 0.95
Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Front Genet (2013) 0.94
MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Sci Rep (2014) 0.94
Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a. Int J Mol Sci (2012) 0.93
Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer (2013) 0.91
Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford) (2012) 0.87
MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma. Int J Clin Exp Med (2014) 0.84
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. PLoS One (2015) 0.84
Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clin Gastroenterol Hepatol (2015) 0.82
Selective secretion of microRNA in CNS system. Protein Cell (2013) 0.82
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? Biochim Biophys Acta (2016) 0.81
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med (2016) 0.81
Extracellular vesicle noncoding RNA: new players in the diagnosis and pathogenesis of cholangiocarcinoma. Hepatology (2014) 0.80
MicroRNAs in Cholangiopathies. Curr Pathobiol Rep (2014) 0.80
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. J Clin Med (2015) 0.79
MicroRNAs and benign biliary tract diseases. Semin Liver Dis (2015) 0.78
Characterization and comparative profiling of miRNAs in invasive Bemisia tabaci (Gennadius) B and Q. PLoS One (2013) 0.78
MicroRNA expression profiles differentiate chronic pain condition subtypes. Transl Res (2015) 0.77
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci (2016) 0.76
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers. Biomed Res Int (2016) 0.75
Extracellular vesicles in liver diseases. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer. Gastroenterol Res Pract (2016) 0.75
Reply: To PMID 21858175. Hepatology (2015) 0.75
Lin28 and let-7: roles and regulation in liver diseases. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther (2017) 0.75
Emerging molecular targets and therapy for cholangiocarcinoma. World J Gastrointest Oncol (2017) 0.75
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 10.28
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A (2008) 7.14
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol (2010) 6.67
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene (2006) 6.61
Detection and characterization of placental microRNAs in maternal plasma. Clin Chem (2008) 6.40
Biliary tract cancers. N Engl J Med (1999) 6.36
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg (2010) 4.59
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis (2008) 3.84
Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem (2002) 3.72
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol (2008) 3.18
Cholangiocarcinoma. Gastroenterology (2005) 3.15
Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis (2009) 3.11
A review and update on cholangiocarcinoma. Oncology (2004) 2.49
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy (1999) 2.02
Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol (2004) 1.86
Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc (1995) 1.86
Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol (2010) 1.85
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology (2005) 1.78
MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J (2009) 1.74
ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc (2004) 1.73
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog (2009) 1.61
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol (2006) 1.60
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc (2002) 1.58
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology (2002) 1.54
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene (2010) 1.53
EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol (2004) 1.47
Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc (1995) 1.46
Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol (2000) 1.44
MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction (2008) 1.44
Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc (2000) 1.42
A prospective evaluation of cytology from biliary strictures. Gut (1997) 1.34
Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol (2007) 1.33
Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol (2004) 1.32
Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol (2000) 1.31
Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol (2001) 1.28
Physiology of bile secretion. World J Gastroenterol (2008) 1.28
MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol (2009) 1.26
Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc (1998) 1.12
EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc (2000) 1.11
Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci (2008) 1.09
A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease. Clin Radiol (1999) 1.07
Benign, dysplastic, or malignant--making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol (1995) 1.03
Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy (2004) 1.02
The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium. J Clin Pathol (2001) 1.02
Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects. Am J Pathol (1987) 1.01
Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc (2002) 0.99
Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. J Hepatobiliary Pancreat Surg (2005) 0.94
Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice. World J Gastroenterol (2008) 0.89
Anatomical variation of pancreatobiliary ducts in biliary stone diseases. Abdom Imaging (1993) 0.87
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell (2007) 14.63
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol Dial Transplant (2007) 2.68
The effect of intraoperative rectal washout on local recurrence after rectal cancer surgery: a meta-analysis. Ann Surg Oncol (2012) 2.38
Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod (2009) 2.17
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol (2009) 1.72
Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol (2005) 1.71
A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of esophageal varices. Am J Gastroenterol (2005) 1.68
Factors associated with diagnostic delay of oral squamous cell carcinoma. Oral Oncol (2003) 1.65
The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest (2007) 1.57
RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS. Brain Res (2006) 1.55
General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc (2010) 1.51
Malignant afferent loop obstruction following pancreaticoduodenectomy: report of two cases. J Nippon Med Sch (2006) 1.48
Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res (2002) 1.48
The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica (2008) 1.46
Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem (2004) 1.44
MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction (2008) 1.44
Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial. Int J Urol (2013) 1.42
Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol Cell Biol (2004) 1.39
Current status of ectopic varices in Japan: Results of a survey by the Japan Society for Portal Hypertension. Hepatol Res (2010) 1.38
Parasystole due to re-entry as the possible mechanism of ventricular parasystole with second-degree entrance block. J Cardiovasc Med (Hagerstown) (2010) 1.37
Identification of neovasculature using nestin in colorectal cancer. Int J Oncol (2007) 1.36
Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest (2002) 1.34
Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer (2002) 1.34
Partial splenic embolization. Hepatol Res (2007) 1.29
MOSAIC FLORAL ORGANS1, an AGL6-like MADS box gene, regulates floral organ identity and meristem fate in rice. Plant Cell (2009) 1.28
Male choriocarcinoma with metastasis to the jejunum: a case report and review of the literature. J Nippon Med Sch (2008) 1.27
Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol (2007) 1.22
Intracystic hemorrhage of a simple hepatic cyst. Hepatogastroenterology (2002) 1.21
Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One (2011) 1.19
Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension (2011) 1.19
Chronic anisakiasis of the ascending colon associated with carcinoma. J Nippon Med Sch (2006) 1.19
MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch (2009) 1.18
superwoman1-cleistogamy, a hopeful allele for gene containment in GM rice. Plant Biotechnol J (2007) 1.18
Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology (2002) 1.17
Life-threatening bleeding from gastrointestinal stromal tumor of the stomach. J Nippon Med Sch (2008) 1.16
Performance evaluation of salivary amylase activity monitor. Biosens Bioelectron (2004) 1.16
Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol (2004) 1.16
Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol (2005) 1.13
The ACC synthase TOE sequence is required for interaction with ETO1 family proteins and destabilization of target proteins. Plant Mol Biol (2006) 1.13
Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma. Int J Oncol (2009) 1.13
Infected hepatic cyst. Hepatogastroenterology (2003) 1.12
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol (2007) 1.10
Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol (2008) 1.10
The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J (2008) 1.10
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744). J Med Chem (2013) 1.09
Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res (2003) 1.09
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci (2007) 1.07
Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus. Virology (2004) 1.07
Resection of over 290 polyps during emergency surgery for four intussusceptions with Peutz-Jeghers syndrome: Report of a case. Surg Today (2006) 1.06
Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res (2007) 1.05
Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem Biophys Res Commun (2003) 1.05
Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun (2002) 1.04
Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol Rep (2006) 1.04
Spurt bleeding from a calcificated gastrointestinal stromal tumor in the stomach. J Nippon Med Sch (2005) 1.04
Clinical outcome of laparoscopic distal pancreatectomy. J Hepatobiliary Pancreat Surg (2008) 1.04
Sexually dimorphic expression of the novel germ cell antigen TEX101 during mouse gonad development. Biol Reprod (2005) 1.03
Inflammatory pseudotumor in the liver associated with intrahepatic bile duct stones mimicking malignancy. J Nippon Med Sch (2009) 1.02
Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett (2005) 1.02
Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis. Hepatogastroenterology (2002) 1.02
Magnetic resonance imaging of gastrointestinal stromal tumor in the abdomen and pelvis. Clin Imaging (2006) 1.02
Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract (2004) 1.02
Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2009) 1.01